监督运动方案治疗间歇性跛行的成本效果:基于MAXIMISE研究的经济学评价
该研究基于MAXIMISE研究构建模型,从医疗 payer 视角比较不同监督运动方案(SEP)与无监督运动的成本效果。
要点
- 多数监督运动方案相比无监督运动具有成本效果。
核心结论
- 多数监督运动方案相比无监督运动具有成本效果。
- 临床最优运动处方与NHS最具价值处方的成本效果差异可能由资源密集度较低处方的实施成本驱动。
研究设计与样本
- 基于MAXIMISE研究的模型化成本效果分析,采用医疗 payer 视角,成本以2023年英镑计。
- 模型将运动对最大步行距离的影响链接至质量调整生命年(QALY)和成本,比较不同SEP配置与无监督运动及彼此之间的差异。
主要发现
- 结果仅对运动效应的合成方式敏感。
临床怎么用
- 多数SEP相比无监督运动具有成本效果,支持将监督运动方案作为间歇性跛行的首选治疗。
- 在NHS资源约束下,间歇步行方案可能提供更优的价值,但需结合临床相关性综合考量。
局限性
- 结果为模型化分析,仅对运动效应的合成方式敏感。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intermittent claudication significantly impairs walking ability and quality of life. Although clinical guidelines recommend supervised exercise programmes (SEPs) as first line treatment, a lack of consensus on the optimal frequency, intensity, time, and type of exercise has delayed implementation. This model based, cost effectiveness analysis study aimed to evaluate the cost effectiveness of alternative SEPs to determine their value for money, based on the MAXIMISE study. METHODS: A de novo model compared SEP configurations varying in their components against unsupervised exercise and each other. The model linked effects of exercise on maximum walking distance to quality adjusted life years (QALYs) and costs (2023 price year in GBP), from the healthcare payer perspective. The cost effective intervention was identified based on the incremental cost effectiveness ratio (ICER) of each exercise intervention (supervised or unsupervised) compared with the next potentially cost effective intervention. Results robustness was explored in scenario analyses. RESULTS: SEPs seemed cost effective compared with unsupervised exercise for most prescriptions. A prescription of 30 - 44 minutes per session (with rest and progression) of high intensity interval cycling thrice weekly for 12 weeks appeared to be cost effective (49% probability at £20 000/QALY; ICER: £5 672/QALY [€6 628/QALY; exchange rate of €1 = £0.85585]). Restricting the analysis to SEPs judged to be of higher quality and or more clinically relevant suggested that the cost effective SEP would consist of sessions of less than 30 minutes (with rest and without progression) of intermittent walking until mild to moderate pain, thrice weekly for 12 weeks (21% probability at £20 000/QALY; ICER: £2 183/QALY [€2 551/QALY]). Results were only sensitive to how exercise effects were synthesised. CONCLUSION: Most SEPs emerged as cost effective compared with unsupervised exercise. Cost effectiveness differences between the clinically identified optimal exercise prescription and the prescription offering the most value for money in the National Health Service seemed to be driven by costs of delivering a prescription that is less resource intensive.
引用
- Chivardi C, Palacios A, Huang C, et al. Cost Effectiveness of Supervised Exercise Programmes for Intermittent Claudication: An Economic Evaluation Based on the MAXIMISE Study. Eur J Vasc Endovasc Surg. 2026. PMID: 42753907. doi:10.1016/j.ejvs.2026.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。